Studies of VYVANSE in Drug Abusers A randomized, double-blind, placebo-control, cross-over, abuse liability study in 38 patients with a history of drug abuse was conducted with single-doses of 50, 100, or 150 mg of VYVANSE, 40 mg of immediate-release d-amphetamine sulphate (a controlled II substance), and 200 mg of diethylpropion hydrochloride (a controlled IV substance)
This central adiposity, which is more common in men than women, infiltrates deeper into the abdomen, inhibits functions of internal organs, and increases susceptibility to cardiometabolic disease
Patient had a significant bulge of stubborn belly fat across the entire abdomen
These include gastrointestinal issues (nausea, vomiting, diarrhea, constipation), pancreatitis, thyroid tumors, gallstones, hair loss, and mental health concerns
Additionally, many of the elemental formulas have added iodine , which can exacerbate Hashimotos in excess amounts